[Persistent neutrophilic meningitis].
García-García
J
J
González-Escoda
E
E
Navarro-López
V
V
Hernández-Lorido
R
R
Gregori-Colomé
J
J
Mola-Caballero de Rodas
S
S
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D002006:Brucellosis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D002177:Candidiasis / Q000175:diagnosis* / Q000188:drug therapy; D003937:Diagnosis, Differential; D005260:Female; D016469:Fungemia / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D008297:Male; D016920:Meningitis, Bacterial / Q000145:classification / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology; D016921:Meningitis, Fungal / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology; D009504:Neutrophils / Q000473:pathology*; D012189:Retrospective Studies; D013030:Spain / Q000453:epidemiology; D014390:Tuberculosis, Meningeal / Q000175:diagnosis
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D000995:Antitubercular Agents